Search PETS
PetMed Express, Inc.
NasdaqGS · CIK 1040130
Last close1.36
Daily change-0.01 (-0.73%)
10 Years gain-56.96%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
PETS · STANDARD
SIC 5912 · Retail-Drug Stores and Proprietary Stores · Fiscal year end 0331
Fundamental
22.1Momentum
0.0Acceleration
0.0Confidence
82.0Annual Revenue13
Quarterly Revenue61
Annual CFO11
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics9.6 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 4.0631 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 30.4345 percentage points.
Key Metrics
Revenue Growth TTM-35.34%OK
Revenue CAGR 3Y-10.24%OK
Gross Margin26.86%OK
Operating Margin-33.41%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-167.09%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y5.08%OK
SBC / Revenue0.73%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Mar 31, 2026 | $179.02M | $50.22M | -$58.67M | -$28.39M | -$33.01M | 28.05% | -32.77% | -18.44% | -244.33% | 20.92M |
| 2026 FY Mar 31, 2025 | $226.97M | $69.14M | -$1.53M | $4.72M | -$395,000.00 | 30.46% | -0.67% | -0.17% | -3.36% | 20.6M |
| 2026 FY Mar 31, 2024 | $274.10M | $84.77M | -$8.16M | $4.32M | -$194,000.00 | 30.93% | -2.98% | -0.07% | -27.26% | 20.4M |
| 2025 FY Mar 31, 2023 | $247.57M | $76.50M | $6.05M | $27.80M | $22.54M | 30.9% | 2.44% | 9.11% | 45.78% | 20.34M |
| 2024 FY Mar 31, 2022 | n/a | $76.94M | $24.29M | $18.50M | $16.75M | n/a | n/a | n/a | 202.33% | 20.36M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $177.22M | sum latest 4 fiscal quarters Revenue | OK | 0001040130-26-000041, 0001040130-25-000108 |
| Revenue Growth TTM | -35.34% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001040130-26-000041, 0001040130-25-000108 |
| Revenue CAGR 3Y | -10.24% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001040130-26-000019 |
| Revenue CAGR 5Y | -6.4% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001040130-26-000019 |
| Gross Profit CAGR 3Y | -13.09% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001040130-26-000019 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001040130-26-000041, 0001040130-25-000108 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 26.86% | Gross Profit / Revenue | OK | 0001040130-26-000041, 0001040130-25-000108 |
| Operating Margin | -33.41% | Operating Income / Revenue | OK | 0001040130-26-000041, 0001040130-25-000108 |
| ROIC | -167.09% | NOPAT / Average Invested Capital | OK | 0001040130-26-000041, 0001040130-25-000108 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001040130-26-000041 |
| Current Ratio | 0.68x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 0.73% | SBC / Revenue | OK | 0001040130-26-000041, 0001040130-25-000108 |
| Revenue per Diluted Share | $8.17 | Revenue / Diluted Shares | OK | 0001040130-26-000041, 0001040130-25-000108 |